AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,357 | N/A | -85,030 | -70,065 | -48,752 |
| Depreciation Amortization | 1,279 | N/A | 3,021 | 2,309 | 1,497 |
| Accounts receivable | -12,552 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -768 | N/A | -715 | -1,153 | 293 |
| Other Working Capital | -9,437 | N/A | -8,177 | -3,720 | -938 |
| Other Operating Activity | 18,037 | 0 | 7,301 | 6,712 | 6,183 |
| Operating Cash Flow | $-19,797 | $N/A | $-83,599 | $-65,916 | $-41,717 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,532 | N/A | 77,969 | 60,585 | 33,700 |
| PPE Investments | -543 | N/A | -1,068 | -972 | -873 |
| Other Investing Activity | 0 | 0 | -205 | -212 | -206 |
| Investing Cash Flow | $20,989 | $N/A | $76,695 | $59,400 | $32,622 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 736 | N/A | 7 | 9 | N/A |
| Other Financing Activity | -557 | 0 | -1,238 | -957 | -612 |
| Financing Cash Flow | $180 | $N/A | $-1,231 | $-948 | $-612 |
| Exchange Rate Effect | -154 | N/A | -3,307 | -3,199 | -3,085 |
| Beginning Cash Position | 33,904 | N/A | 43,784 | 45,326 | 43,973 |
| End Cash Position | 35,121 | N/A | 32,342 | 34,662 | 31,180 |
| Net Cash Flow | $1,217 | $N/A | $-11,442 | $-10,663 | $-12,792 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,797 | N/A | -83,599 | -65,916 | -41,717 |
| Capital Expenditure | -543 | N/A | -1,086 | -991 | -891 |
| Free Cash Flow | -20,340 | 0 | -84,686 | -66,907 | -42,608 |